LPAR1 and pulmonary fibrosis: LPA1 has been implicated in cancer invasion, lung fibrosis, autoimmune disorders, hydrocephalus, and neuropathic pain, and LPA1 antagonists have been under development for treating autoimmune diseases and cancers [68, 69].